#8 - Pioneering Continuous Glucose Monitoring: Insights from Bill Van Antwerp

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/95/bb/5c/95bb5c94-80e5-47d2-fb28-919fad379cba/mza_6306474668100189866.jpg/600x600bb.jpg

Action Potential

Slice of Healthcare

10 episodes

6 months ago

Unveiling the Future of Potassium Monitoring. Dive into the nexus of medical innovation and clinical expertise, as we spotlight the game-changers in healthcare and explore the transformative power of continuous potassium data. Join us on a journey of discovery, from the intricacies of hyperkalemia to the voices that shape the future of patient-centric care. Powered by ProtonIntel’s groundbreaking technology, we’re setting new standards and redefining the pulse of modern medicine.

All content for Action Potential is the property of Slice of Healthcare and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

#8 - Pioneering Continuous Glucose Monitoring: Insights from Bill Van Antwerp

Action Potential

43 minutes

1 year ago

#8 - Pioneering Continuous Glucose Monitoring: Insights from Bill Van Antwerp

Welcome back to Action Potential, join us this week as we welcome Bill Van Antwerp, Founder and CSO at Laxmi, a leading expert in diabetes care.

What you'll get from this episode:

Trailblazing in Remote Physiological Monitoring: Bill Van Antwerp shares his extensive experience in developing insulin pumps and the first FDA-approved CGM (Continuous Glucose Monitor), paving the way for modern diabetes care.
Innovative Solutions Overcoming Manufacturing Challenges: Van Antwerp discusses the complex journey from concept to mass production, highlighting the difficulty in manufacturing reliable, consistent sensors at scale.
The Evolution of CGM Technology: He reflects on the evolution of CGM, from initial skepticism and regulatory hurdles to its current status as a standard care tool for managing diabetes.
Patient Empowerment through Technology: Van Antwerp emphasizes how CGMs have empowered patients, particularly in making informed decisions based on real-time data, a significant shift from the earlier FDA restrictions.
Future Directions in Sensor Technology: Looking ahead, Van Antwerp discusses the potential of non-invasive methods and the importance of directly measuring targeted analytes for accurate and clinically actionable data.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Bill Van Antwerp: https://www.linkedin.com/in/bill-van-antwerp-35848052/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/